Volume 13 (2006): Issue 1 (Mar 2006)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-0088

Articles are added to the current issue and list of accepted manuscripts on an ongoing basis, reflecting the journal's continuous publication.

Sign up using the button to receive email notifications of the latest research.

Sign up for journal news
Welcome from the new Editor-in-Chief
Author(s): James A Fagin
Pages: 1
New free access option
Pages: 2
Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?
Author(s): Nicola Normanno and William J Gullick
Pages: 3–6
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
Author(s): Michele Caraglia, Daniele Santini, Monica Marra, Bruno Vincenzi, Giuseppe Tonini, and Alfredo Budillon
Pages: 7–26
TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?
Author(s): Lei Zhang and Gregory J Barritt
Pages: 27–38
Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer
Author(s): P Kauraniemi and A Kallioniemi
Pages: 39–49
Clinical trials with retinoids for breast cancer chemoprevention
Author(s): S Zanardi, D Serrano, A Argusti, M Barile, M Puntoni, and A Decensi
Pages: 51–68
Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas
Author(s): Sandra Valéria de Sá, Maria Lúcia Corrêa-Giannella, Márcio Carlos Machado, Jean Jorge S de Souza, Maria Adelaide Albergaria Pereira, Rosely Antunes Patzina, Sheila Aparecida Coelho Siqueira, Marcel Cerqueira César Machado, and Daniel Giannella-Neto
Pages: 69–78
Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma
Author(s): G Galli, R Zonefrati, A Gozzini, C Mavilia, V Martineti, I Tognarini, G Nesi, T Marcucci, F Tonelli, M Tommasi, C Casini Raggi, P Pinzani, and M L Brandi
Pages: 79–93
A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone
Author(s): Eric Ueda, Ugur Ozerdem, Yen-Hao Chen, Min Yao, Kuang Tzu Huang, Huiqin Sun, Manuela Martins-Green, Paolo Bartolini, and Ameae M Walker
Pages: 95–111
Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells
Author(s): Susan M Dougherty, Williard Mazhawidza, Aimee R Bohn, Krista A Robinson, Kathleen A Mattingly, Kristy A Blankenship, Mary O Huff, William G McGregor, and Carolyn M Klinge
Pages: 113–134
The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours
Author(s): Michael Höpfner, Viola Baradari, Alexander Huether, Christof Schöfl, and Hans Scherübl
Pages: 135–149
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells
Author(s): Ta-Chun Yuan, Suresh Veeramani, Fen-Fen Lin, Dmitry Kondrikou, Stanislav Zelivianski, Tsukasa Igawa, Dev Karan, Surinder K. Batra, and Ming-Fong Lin
Pages: 151–167
Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma
Author(s): K-M Fung, E N S Samara, C Wong, A Metwalli, R Krlin, B Bane, C Z Liu, J T Yang, J V Pitha, D J Culkin, B P Kropp, T M Penning, and Hsueh-Kung Lin
Pages: 169–180
Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells
Author(s): S Humez, M Monet, G Legrand, G Lepage, P Delcourt, and N Prevarskaya
Pages: 181–195
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
Author(s): Adriano Angelucci, Giovanni Luca Gravina, Nadia Rucci, Danilo Millimaggi, Claudio Festuccia, Paola Muzi, Anna Teti, Carlo Vicentini, and Mauro Bologna
Pages: 197–210
Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway
Author(s): Ki-Yon Kim, Kyung-Chul Choi, Nelly Auersperg, and Peter C K Leung
Pages: 211–220
Role of exon-16-deleted HER2 in breast carcinomas
Author(s): F Castiglioni, E Tagliabue, M Campiglio, S M Pupa, A Balsari, and S Ménard
Pages: 221–232
Peroxisome proliferator-activated receptor γ in human breast carcinoma: a modulator of estrogenic actions
Author(s): T Suzuki, S Hayashi, Y Miki, Y Nakamura, T Moriya, A Sugawara, T Ishida, N Ohuchi, and H Sasano
Pages: 233–250
Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre
Author(s): K L Cheung, R Owers, and J F R Robertson
Pages: 251–255
The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane
Author(s): G Riesco-Eizaguirre, P Gutiérrez-Martínez, M A García-Cabezas, M Nistal, and P Santisteban
Pages: 257–269
Erratum
Pages: 271
  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821